Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross‐sectional study
- Published on 22/07/2025
- Reading time: 5 min.
Madeleine J Marsland 1,2, Tilda N Thomson 1,2, Helen M O'Brien 1, Elizabeth Peach 3, Jody Bellette 3, Nicole Humphreys 3, Clare‐Anne McKeon 4, William Cross 4, Michael A Moso 5, Mitchell Batty 5, Suellen Nicholson 5, Theo Karapanagiotidis 5, Chuan Kok Lim 5, Deborah A Williamson 5, Noni Winkler 6, Archana Koirala 6, Kristine Macartney 6, Anna Glynn‐Robinson 2, Tony Stewart 2, Corinna Minko 1, Kathryn J Snow 1, Jim Black 1, N Deborah Friedman 1
1
Victorian Department of Health
Melbourne
VIC
Australia
2
National Centre for Epidemiology and Population Health
Australian National University
Canberra
ACT
3
Albury Wodonga Health
Wodonga
NSW
4
Goulburn Valley Health
Shepparton
VIC
5
Victorian Infectious Diseases Reference Laboratory, Doherty Institute for Infection and Immunity
Royal Melbourne Hospital
Melbourne
VIC
6
National Centre for Immunisation Research and Surveillance
Sydney Children's Hospitals Network
Sydney
NSW
Abstract
Objectives To investigate the distribution and prevalence of Japanese encephalitis virus (JEV) antibody (as evidence of past infection) in northern Victoria following the 2022 Japanese encephalitis outbreak, seeking to identify groups of people at particular risk of infection; to investigate the distribution and prevalence of antibodies to two related flaviviruses, Murray Valley encephalitis virus (MVEV) and West Nile virus Kunjin subtype (KUNV).
Study design...
To continue reading this article in Full-Text...
Search | Advanced search
Articles by topics
